Why Geron Stock Is Soaring Today

Why Geron Stock Is Soaring Today

Shares of Geron (NASDAQ: GERN) were trading up by 35.8% as of 11:33 a.m. EDT on Friday. The big jump came after the company published data from its phase 2 clinical study evaluating imetelstat as a treatment for myelofibrosis, a rare type of bone marrow cancer. Geron's latest results were published in the Journal of Clinical Oncology.